OMDYMA

What this means for you

This application is over — abandoned 12 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88705135

Mark type

Stylized text

Filed

25 Nov 2019

Published for opposition

17 Nov 2020

Abandoned

12 Feb 2024

Attorney of record

Monica Riva Talley

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, treatment and management of superoxide mediated conditions; biotechnological preparations for medical use being biological preparations for the treatment of cancer, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, and radiation protection

Owner

• Galera Therapeutics, Inc., Malvern, PA, US
• Galera Therapeutics, Inc., Malvern, PA, US

Prosecution history

• 12 Feb 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 12 Feb 2024 — ABANDONMENT - NO USE STATEMENT FILED
• 13 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 12 Jul 2023 — SOU EXTENSION 5 GRANTED
• 26 Jun 2023 — SOU EXTENSION 5 FILED
• 03 Jul 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 26 Jun 2023 — SOU TEAS EXTENSION RECEIVED
• 03 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 30 Dec 2022 — SOU EXTENSION 4 GRANTED
• 30 Dec 2022 — SOU EXTENSION 4 FILED
• 30 Dec 2022 — SOU TEAS EXTENSION RECEIVED
• 02 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 30 Jun 2022 — SOU EXTENSION 3 GRANTED
• 30 Jun 2022 — SOU EXTENSION 3 FILED
• 30 Jun 2022 — SOU TEAS EXTENSION RECEIVED